| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.09 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |